Daniel E. Abbott, MD, FACS

Professor

  • Surgical Director, UW Health Liver and Pancreas Center
  • Division of Surgical Oncology

abbott@surgery.wisc.edu
(608) 262-2025

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792

Education

  • MD, University of Washington School of Medicine, Seattle, Washington, 2003
  • General Surgery Residency, Northwestern University/Feinberg School of Medicine, Chicago, Illinois, 2010
  • Research Fellowship, Children's Memorial Research Center/Northwestern University, Division of Cancer Biology and Epigenomics, Chicago, Illinois, 2008
  • Surgical Oncology Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2012

Clinical Specialties

Dr. Abbott is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. Trained specifically in cancer surgery at The University of Texas MD Anderson Cancer Center, his clinical focus is on gastrointestinal malignancies, as well as melanoma and sarcoma. He performs both traditional and laparoscopic resections for cancers of the liver, pancreas, and stomach. As Director of Cytoreductive and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery, he is particularly interested in patients with peritoneal spread of appendiceal, colorectal and ovarian cancers. Dr. Abbott is active in a number of national organizations, including the Society of Surgical Oncology, the American Hepatopancreaticobiliary Association, the Association for Academic Surgery, and the Society of University Surgeons.

Research Interests

Dr. Abbott, a health services researcher, focuses on cost-effectiveness, systems efficiency, and socioeconomic disparity in cancer care. He is particularly interested in identifying opportunities to maintain or enhance cancer care using technology in a patient-centered manner and thereby helping patients access expert cancer care in more personalized settings.

Recent Publications

  • ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
    Beal EW, Srinivas S, Shen C, Kim A, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Grotz TE, Leiting JL, Fournier K, Dineen S, Powers B, Veerapong J, Kothari A, Maduekew U, Maithel S, Wilson GC, Patel SH, Lambert L, Abdel-Misih S, Cloyd JM
    Ann Surg Oncol 2022 Nov 23;
    [PubMed ID: 36418799]

  • Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
    Beal EW, Srinivas S, Shen C, Kim A, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Grotz TE, Leiting JL, Fournier K, Dineen S, Powers B, Veerapong J, Kothari A, Maduekew U, Maithel S, Wilson GC, Patel SH, Lambert L, Abdel-Misih S, Cloyd JM
    Ann Surg Oncol 2022 Oct 30;
    [PubMed ID: 36310315]

  • Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.
    Turner KM, Morris MC, Delman AM, Hanseman D, Johnston FM, Greer J, Walle KV, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Maduekwe U, Kothari A, Staley CA, Maithel SK, Lambert LA, Kim AC, Cloyd JM, Wilson GC, Sussman JJ, Ahmad SA, Patel SH
    J Gastrointest Surg 2022 Dec; 26(12): 2569-2578
    [PubMed ID: 36258061]

  • ASO Visual Abstract: Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma-Results from the US Extrahepatic Biliary Malignancy Consortium.
    Toyoda J, Sahara K, Maithel SK, Abbott DE, Poultsides GA, Wolfgang C, Fields RC, He J, Scoggins C, Idrees K, Shen P, Endo I, Pawlik TM
    Ann Surg Oncol 2022 Nov; 29(12): 7617-7618
    [PubMed ID: 35902497]

  • Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
    Toyoda J, Sahara K, Maithel SK, Abbott DE, Poultsides GA, Wolfgang C, Fields RC, He J, Scoggins C, Idrees K, Shen P, Endo I, Pawlik TM
    Ann Surg Oncol 2022 Nov; 29(12): 7605-7614
    [PubMed ID: 35768667]

All Publications on PubMed